Dispatch 3: Shared Immunity

“What is the sweetest thing in the world?” After co-host Latif Nasser’s sons ask him this deceptively simple question, he goes on a quest to find it. Is it a West African Katemfe berry? Or an industrial sugar substitute cooked up in a lab? Or an ingredient hiding in plain sight i ...  Show more

When Kelley Benham and her husband Tom French finally got pregnant, after many attempts and a good deal of technological help, everything was perfect. Until it wasn't. Their story raises questions that, until recently, no parent had to face… and that are still nearly impossible t ...  Show more

Research from New York examining the blood of people who have recovered from Covid – 19 shows the majority have produced antibodies against the disease, The researchers hope to soon be able to establish whether this confers long term immunity as with more common viral infections. ...  Show more

Throughout the pandemic there’s been a big question: Will recovering from the virus or being treated by an effective vaccine provide lasting immunity? CNN Contributor Erin Bromage shares why new studies from the last few weeks make him more hopeful than ever that the answer could ...  Show more

There’s a ton of hoopla over these new coronavirus vaccines. But given that they’ve been produced at warp speed — can we trust them? We also find out what’s going on with “long haulers.” How common is it to be sick for months from Covid-19? Plus, fresh new science about why some ...  Show more

Dr. Ian Lustbader, Clinical Professor of Medicine at NYU Langone, explains why people who recovered from Covid appear to have a lower risk of contracting the delta variant than those who got the Pfizer shot. Matt Baker, Chief Strategy Officer at Dell, discusses earnings results a ...  Show more